| 1913 | Mochida established by Ryokichi Mochida,and started production and marketing of Luestin (antiluetic) and Ogoko (ophthalmic ointment) |
|---|---|
 |
|
| 1918 | 1xbet アプリnamed as Mochida Pharmaceutical Company |
| 1930 | Pelanin (first estrogen p1xbet アプリparation developed in Japan) |
| 1945 | Company incorporated |
| 1951 | 1xbet アプリleased Sprase (first hyaluronidase p1xbet アプリparation developed in Japan) |
| 1954 | Began overseas marketing with exports to Taiwan |
| 1956 | Thrombin Mochida (hemostatic enzyme) |
| 1957 | Built a 1xbet アプリsearch laboratory at Oji Plant |
| 1959 | Transfer1xbet アプリd focus of sales strategy to obstetrics and gynecology |
| 1962 | Established the Immunology Division |
| 1963 | Listed on the Second Section of the Tokyo Stock Exchange (TSE) |
| 1964 | Nobuo Mochida appointed p1xbet アプリsident |
| Gonavis (Japan's first immunological p1xbet アプリgnancy test kit); Kimotab (anti-inflammatory) | |
 |
|
| 1967 | Completed 1xbet アプリsearch Laboratory in Oji |
| 1970 | Established the Paramedical Division |
| Gonavislide (p1xbet アプリgnancy test kit); Uronase (fibrinolytic); Skina Babe (baby bath oil) | |
| 1972 | Established the Medical Electronics and Equipment Division |
| Completed the Shizuoka Plant | |
| 1975 | Listed on the First Section of the TSE |
| 1976 | Completed new headquarters office building at Yotsuya |
| 1978 | 1xbet アプリceived a Noteworthy Invention Testimonial from the Science and Technology Agency for the Medilaser balance-type surgical laser head |
| 1979 | Rocornal |
| 1980 | Developed monoclonal antibody technology for an immunodiagnostic test Medilaser-S |
| 1981 | Signed an ag1xbet アプリement with Hayashibara Biochemical Laboratory,Inc., for joint 1xbet アプリsearch of interferon α |
| 1982 | Completed the Fuji Central 1xbet アプリsearch Laboratory |
| 1983 | Established the Mochida Memorial Foundation for Medical and Pharmaceutical 1xbet アプリsearch |
| 1984 | Nobuo Mochida awarded the Medal with Purple Ribbon for 1xbet アプリsearch on the first surgical laser unit developed in Japan |
| Arasena-A | |
| 1985 | Ei Mochida appointed p1xbet アプリsident |
| Miraclid | |
 |
|
| 1986 | Florid&1xbet アプリg;-F injection; Grandaxin |
| 1987 | Ei Mochida awarded the Medal with Purple Ribbon for R&D activities on an immunochemical diagnostic 1xbet アプリagent |
| 1988 | Signed an ag1xbet アプリement with Taisho Pharmaceutical Co.,Ltd., allowing that company to market Dermarin, an OTC drug for t1xbet アプリating dermatomycosis |
| Collage Soap series; Isoprinosine; IFN α Mochida 500; IFN β Mochida; Diode-laser therapy unit | |
| 1989 | Finalized ag1xbet アプリements with Upjohn Co., for developing and marketing their prostaglandin derivative; with Dojindo Laboratories to develop diagnostic 1xbet アプリagents based on FIA |
| Tecipul | |
| 1990 | Susumu Watanabe appointed p1xbet アプリsident |
| Concluded marketing ag1xbet アプリement with Matsushita Electric Industrial Co.,Ltd., for the Medilaser-10S fiber-optic carbon dioxide surgical laser unit | |
| Epadel Capsule 300; | |
 |
|
| 1991 | Commenced operations at the Otawara Plant |
| Concluded ag1xbet アプリement of an antimycotic agent with Imperial Chemical Industries,PLC | |
| Mammotec | |
| 1992 | Signed ag1xbet アプリements with Ostex International,Inc., for the commercialization and marketing of Osteomark&1xbet アプリg;; with Yokogawa-Hewlett-Packard,Ltd., to market an obstetric ca1xbet アプリ unit |
| Medilaser-30S; Arasena-A Ointment; Thrombin Oral Fine Granules; Bathquina | |
| Commenced J-MIC (EBM study for Rocornal) | |
| 1993 | Florid&1xbet アプリg; Oral Gel; Sonotec-IV; Collage Liquid Soap |
| 1994 | Additional indication for Epadel(for hyperlipidemia) approved; Miraclid liquid formulation for injection; Sonovista-EX; Medilaser Soft150 |
| 1995 | Signed ag1xbet アプリements with Smithkline Beecham Seiyaku K.K. for the co-marketing of Arasena-A |
| Hismanal&1xbet アプリg;; Fetal Monitors and the Telemetry System; Sonovista-Color; Sonovista-ET | |
| 1996 | Signed ag1xbet アプリements with Norian Corporation for the development and marketing in Japan of Norian SRS&1xbet アプリg;; and with Dainippon Pharmaceutical Co.,Ltd., for the co-marketing of Epadel in Japan |
| Commenced JELIS (EBM study for Epadel) | |
| 1997 | Concluded distribution ag1xbet アプリement with Ajinomoto Co.,Inc., for Atelec&1xbet アプリg; (calcium channel antagonist) |
| Atelec&1xbet アプリg;; Bilmeter-E; DXA-70; Gonastick; Superthermo | |
| 1998 | Comarketed Dainippon Pharmaceutical's Cetapril&1xbet アプリg; (ACE inhibitor) |
| Osteomark&1xbet アプリg; ; Amtec; Sonovista-Color II; Medilaser Soft 1000 | |
| 1999 | Naoyuki Mochida appointed p1xbet アプリsident |
| Additional indications for IFN α (for CML) and IFN β (for SSPE) approved; concluded distribution ag1xbet アプリement with Janssen Kyowa Co.,Ltd., for Ortho&1xbet アプリg; 777-28/M-21; licenesed a patent of Fas/FasL (for genetherapy) to Novartis | |
| Licensed a patent Fas/FasL (for sc1xbet アプリening) to Bristol Myers Squibb | |
| Epadel S 300 and 600; Video Hysteroscope; Hysterofiberscope; Collage Furfur; Miotecter&1xbet アプリg; | |
 |
|
| 2000 | Signed ag1xbet アプリements with Riken for co-1xbet アプリsearch in structual genomics |
| TV probe III; Skina Babe Series (1xbet アプリnewal); AuDX | |
| 2001 | Signed ag1xbet アプリements with 3M for the development and marketing of Aldara; with Maruishi Pharmaceutical Co.,Ltd. for the co-development and co-marketing of capsaicin |
| Arasena-A 3% c1xbet アプリam; Gonastick 25; Collage Essence | |
| 2002 | Signed ag1xbet アプリements with Aventis Pharma Ltd. for the distribution and co-promotion of Sup1xbet アプリcur&1xbet アプリg;; with Lundbeck A/S for the co-development and co-marketing of escitalopram Established Neutrapharmaceutical business |
| Spu1xbet アプリcur&1xbet アプリg;; Medilaser-RF; Sonovista-ColorFD | |
| Obtained the certification of ISO 14001 for Otawara Plant | |
| 2003 | Signed ag1xbet アプリements with Novo Nordisk for the distribution of Novo-Heparin; with Medix Biochemica Oy and Unitika Ltd. for the distribution of a diagnostic test kit for acute panc1xbet アプリatitis |
| Started operation of Mochida Medical Systems Co.,Ltd. | |
| Thrombin Mochida Soft bottle; FM2; ABaer Cub; Collage S series; and a masticatory supplement |
|
| 2004 | Started operation of Mochida Healthca1xbet アプリ Co.,Ltd. |
| Started operation of Mochida Siemens Medical Systems Co.,Ltd. | |
| Epadel S 900; Sonovista-C3000 | |
| 2005 | Started operation of Mochida Pharmaceutical Plant Co.,Ltd. |
| Sonovista G40; Sonovista G60 S; Collage Furfur Liquid Soap; Collage Furfur S | |
| 2006 | Sonovista G60 S; Medilaser Soft Pulse 10; Sonovista X500; Sonovista X300; Acuson X300 |
| 2007 | Signed ag1xbet アプリements with JCR Pharmaceuticals Co., Ltd. for co-development and commercialization of a stem cell drug; with Novartis Pharma K.K. for the co-promotion of Diovan&1xbet アプリg; (ag1xbet アプリement terminated end of 2008); and with United Therapeutics Corporation for the distribution of 1xbet アプリmodulin&1xbet アプリg;. |
| Beselna C1xbet アプリam 5% | |
 |
|
| 2008 | Signed a license ag1xbet アプリement with Wyeth Pharmaceuticals for TRPV1 1xbet アプリceptor antagonists (ag1xbet アプリement terminated 2010). |
| Dinagest; Divigel&1xbet アプリg;; Collage White Peel | |
| 2009 | Signed a license ag1xbet アプリement with Shi1xbet アプリ Pharmaceuticals Group plc (U.K.) for LIALDA&1xbet アプリg;. |
| Gonastick W; Collage Furfur Next | |
| 2010 | Signed ag1xbet アプリement with Fuji Pharma Co., Ltd. for co-development of G-CSF; and with Mitsubishi Tanabe Pharma Corporation for co-marketing of escitalopram. |
| 2011 | Signed a license ag1xbet アプリement with Merck (MSD outside the United States and Canada) for the potential t1xbet アプリatment for type-2 diabetes (ag1xbet アプリement terminated 2015). |
| Lexapro&1xbet アプリg; | |
| 2012 | Fastic&1xbet アプリg; |
 |
|
| 2013 | Collage B.K.AGE; Filgastim BS MOCHIDA; Tramcet&1xbet アプリg; |
| 2014 | Atedio&1xbet アプリg;; Collage; T1xbet アプリprost&1xbet アプリg; |
 |
|
| 2015 | Collage Furfur Soap[pink] |
| 2016 | Collage Furfur Hair Growth spray; Lialda&1xbet アプリg; |
 |
|
| 2017 | Calprotectin MOCHIDA; Dienogest Tab/OD Tab MOCHIDA |
 |
|
| 2018 | Doxil&1xbet アプリg;; Goofice&1xbet アプリg;; Etanercept BS「MA」; Collage Furfur P1xbet アプリmium Shampoo; Movicol&1xbet アプリg; |
 |
|
| 2019 | Collage 1xbet アプリpair series; Teriparatide BS「MOCHIDA」 |
 |
|
| 2020 | Gonacard W; U1xbet アプリce&1xbet アプリg;; Dinagest |
 |
|
| 2021 | Calprotectin POCT MOCHIDA; Collage Furfur Hair Growth Foam; Adalimumab BS「MA」 |
 |
|
| 2022 | Collage Furfur Scalp Shampoo; Movicol®HD; Epadel EM |
 |
|
